{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:42:04Z","timestamp":1780058524097,"version":"3.54.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.metabol.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T22:32:56Z","timestamp":1458340376000},"page":"893-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits"],"prefix":"10.1016","volume":"65","author":[{"given":"Tsutomu","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritaka","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2016.03.010_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.03.010_bb0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2016.03.010_bb0015","doi-asserted-by":"crossref","first-page":"606031","DOI":"10.1155\/2015\/606031","article-title":"Recent advances in dipeptidyl-peptidase-4 inhibition therapy: Lessons from the bench and clinical trials","volume":"2015","author":"Zhong","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2016.03.010_bb0020","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00125-006-0340-2","article-title":"Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes","volume":"49","author":"Matikainen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2016.03.010_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/FJC.0b013e31821e5626","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"58","author":"Ta","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.07.053","article-title":"A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein e\u2013deficient mice","volume":"59","author":"Matsubara","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/en.2012-1855","article-title":"Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice","volume":"154","author":"Ervinna","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2016.03.010_bb0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.metabol.2011.11.011","article-title":"Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E\u2013null mice","volume":"61","author":"Terasaki","year":"2012","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2016.03.010_bb0045","doi-asserted-by":"crossref","first-page":"e70933","DOI":"10.1371\/journal.pone.0070933","article-title":"Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice","volume":"8","author":"Terasaki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2016.03.010_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2840-13-32","article-title":"The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms","volume":"13","author":"Zeng","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0055","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.111.041418","article-title":"Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis","volume":"124","author":"Shah","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.03.010_bb0060","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.03.010_bb0065","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.03.010_bb0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.03.010_bb0075","first-page":"81","article-title":"Experimental cholesterol arteriosclerosis and its relationship to human atherosclerosis","volume":"20","author":"Duff","year":"1935","journal-title":"Arch Pathol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(93)90080-E","article-title":"The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and the atherosclerotic lesion formation","volume":"102","author":"Bocan","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.03.010_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2013.08.030","article-title":"Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins","volume":"231","author":"Shiomi","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.03.010_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/ATVBAHA.112.300445","article-title":"Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits","volume":"33","author":"Wang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0095","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s12020-014-0376-x","article-title":"The effect of anagliptin treatment on glucose metabolism and lipid metabolism, and oxidative stress in fasting and postprandial states using a test meal in Japanese men with type 2 diabetes","volume":"48","author":"Kakuda","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2016.03.010_bb0100","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/pr400069f","article-title":"Quantitative analytical method for determining the levels of gastric inhibitory polypeptides GIP1-42 and GIP3-42 in human plasma using LC\u2013MS\/MS\/MS","volume":"12","author":"Miyachi","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2016.03.010_bb0105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)30123-1","article-title":"A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC","volume":"43","author":"Usui","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2016.03.010_bb0110","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1194\/jlr.D800017-JLR200","article-title":"Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS\/MS","volume":"49","author":"Honda","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2016.03.010_bb0115","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.metabol.2013.01.010","article-title":"Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet","volume":"62","author":"Nakaya","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.03.010_bb0120","first-page":"847","article-title":"Pharmacokinetics and pharmacodynamics of single and multiple doses of anagliptin, a novel inhibitor of dipeptidyl peptidase-4","volume":"40","author":"Sumami","year":"2012","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1016\/j.metabol.2016.03.010_bb0125","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.ATV.17.11.2376","article-title":"beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits","volume":"17","author":"Holvoet","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.ATV.16.4.533","article-title":"Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits","volume":"16","author":"Stapr\u00e3ns","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2006.04.081","article-title":"Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: A prospective study","volume":"48","author":"Strandberg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0140","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.03.010_bb0145","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2016.03.010_bb0150","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.03.010_bb0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1479164113481817","article-title":"The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(\u2212\/\u2212) mouse model","volume":"10","author":"Gaspari","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.metabol.2016.03.010_bb0160","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00125-011-2241-2","article-title":"Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice","volume":"54","author":"Nagashima","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2016.03.010_bb0165","doi-asserted-by":"crossref","first-page":"e35683","DOI":"10.1371\/journal.pone.0035683","article-title":"Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice","volume":"7","author":"Nogi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2016.03.010_bb0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijcard.2014.09.016","article-title":"Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells","volume":"177","author":"Brenner","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0175","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3109\/09537104.2012.721907","article-title":"Sitagliptin: Anti-platelet effect in diabetes and healthy volunteers","volume":"23","author":"Gupta","year":"2012","journal-title":"Platelets"},{"key":"10.1016\/j.metabol.2016.03.010_bb0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.numecd.2005.07.003","article-title":"In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits","volume":"16","author":"Karantonis","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2016.03.010_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clinbiochem.2008.09.113","article-title":"Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failureFadini GP","volume":"42","author":"Detopoulou","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2016.03.010_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","article-title":"Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1","volume":"55","author":"Avogaro","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.metabol.2016.03.010_bb0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2010.08.064","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes","volume":"213","author":"Ta","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.03.010_bb0200","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.03.010_bb0205","doi-asserted-by":"crossref","first-page":"e66520","DOI":"10.1371\/journal.pone.0066520","article-title":"Soluble CD26\/dipeptidyl peptidase IV enhances the transcription of IL-6 and TNF-\u03b1 in THP-1 cells and monocytes","volume":"8","author":"Ikeda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2016.03.010_bb0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.8101391","article-title":"Direct association of adenosine deaminase with a T cell activation antigen, CD26","volume":"261","author":"Kameoka","year":"1993","journal-title":"Science"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:10:02Z","timestamp":1758427802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0026049516000688"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.03.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}